Research Outputs

Now showing 1 - 3 of 3
No Thumbnail Available
Publication

The FTO rs17817449 polymorphism is not associated with sedentary time, physical activity, or cardiorespiratory fitness: Findings from the GENADIO cross-sectional study

2021, Dra. Mardones-Leiva, Lorena, Dra. Troncoso-Pantoja, Claudia, Dr. Villagrán-Orellana, Marcelo, Martorell, Miquel, Petermann-Rocha, Fanny, Martinez-Sanguinetti, Maria Adela, Leiva-Ordoñez, Ana Maria, Flores, Fernando, Cigarroa, Igor, Perez-Bravo, Francisco, Ulloa, Natalia, Mondaca-Rojas, Daniel, Diaz-Martinez, Ximena, Celis-Morales, Carlos

Background: Genetic variants within the FTO gene have been associated with increased adiposity and metabolic markers; however, there is limited evidence regarding the association of FTO gene variants with physical activity-related variables. The authors aimed to investigate the association of the rs17817449 single-nucleotide polymorphism of FTO with physical activity, sedentary time, and cardiorespiratory fitness in Chilean adults. Methods: A total of 409 participants from the GENADIO study were included and genotyped for the rs17817449 single-nucleotide polymorphism of FTO in this cross-sectional study. Physical activity and sedentary time were measured with ActiGraph accelerometers. Cardiorespiratory fitness was assessed using the Chester step test. The associations were assessed by using multivariate regression analyses. Results: No associations were found for FTO variant with physical activity levels and cardiorespiratory fitness. The risk allele (G) of the FTO was found to be associated with sedentary time in the minimally adjusted model (β = 19.7 min/d; 95% confidence interval, 4.0 to 35.5, per each copy of the risk allele; P = .006), but the association was no longer significant when body mass index was included as a confounder (P = .211). Conclusion: The rs17817449 single-nucleotide polymorphism of the FTO gene was not associated with the level of physical activity, cardiorespiratory fitness, and sedentary behaviors in Chilean adults.

Thumbnail Image
Publication

Number of years with type 2 diabetes is associated with cognitive impairment in Chilean older adults: A cross-sectional study

2021, Dra. Troncoso-Pantoja, Claudia, Dra. Mardones-Leiva, Lorena, Agnieszka Bozanica, Petermann-Rocha, Fanny, Waddell, Heather, Parra-Soto, Solange, Cuevas, Carla, Richardson, Claire, Martínez-Sanguinetti, María Adela, Leiva-Ordoñez, Ana María, Nazar, Gabriela, Villagrán, Marcelo, Martorell, Miquel, Mateo, Eva Ariño, Ochoa-Rosales, Carolina, Diaz-Martinez, Ximena, Ulloa, Natalia, Celis-Morales, Carlos

Introduction: The average life expectancy, as well as the prevalence of Type 2 diabetes (T2D), is increasing worldwide. Population-based studies have demonstrated that the duration of T2D has been associated with cognitive impairment. However, despite the high prevalence of T2D and cognitive impairment in Chile, the association between years with T2D and suspicion of cognitive impairment has not yet been investigated. The objective of this study was to investigate the association between duration of T2D and suspicion of cognitive impairment in Chilean older adults. Material and Methods: 1,040 older adults aged ≥60 years from the Chilean National Health Survey (2009-2010) were included. Suspicion of cognitive impairment was assessed by the abbreviated Mini-Mental State Examination (MMSE). The number of years with T2D was self-reported and categorised into four groups. Poisson Regression analysis was used to assess the association between altered MMSE and the number of years with DM2, adjusted by potential confounders including socio-demographic, lifestyle, adiposity and health-related factors. Results: When the analyses were adjusted for socio-demographic factors, people who had T2D for 15 to 24 and ≥25 years had 2.2-times (95%CI: 1.07; 3.33) and 5.8-times (95%CI: 3.81; 11.0) higher relative risk (RR) of cognitive impairment, compared to those without T2D. When the analyses were additionally adjusted for lifestyle and health-related covariates, the RR for cognitive impairment was 1.76-times (95%CI: 1.02; 2.50) and 4.54-times (95%CI: 2.70; 6.38) higher for those who had T2D for 14-24 years and ≥25 years, respectively. Conclusions: Number of years with T2D was associated with suspicion of cognitive impairment. A longer duration of T2D was associated with a higher likelihood of cognitive impairment in the Chilean older population, independently of confounder factors included in the study.

Thumbnail Image
Publication

Association between walking pace and diabetes: Findings from the Chilean National Health Survey 2016-2017

2020, Dr. Garrido-Méndez, Alex, Dr. Matus-Castillo, Carlos, Dra. Troncoso-Pantoja, Claudia, Cigarroa, Igor, Espinoza-Sanhueza, María, Lasserre-Laso, Nicole, Diaz-Martinez, Ximena, Martinez-Sanguinetti, María, Leiva, Ana, Petermann-Rocha, Fanny, Parra-Soto, Solange, Concha-Cisternas, Yeny, Martorell, Miquel, Ulloa, Natalia, Waddell, Heather, Celis-Morales, Carlos

Background: Walking pace is a well-known indicator of physical capability, but it is also a strong predictor of type 2 diabetes (T2D). However, there is a lack of evidence on the association between walking pace and T2D, specifically, within developing countries such as Chile. Aim: To investigate the association between self-reported walking pace and T2D in the Chilean adult population. Methods: 5520 Chilean participants (aged 15 to 90 years, 52.1% women) from the Chilean National Health Survey 2016–2017 were included in this cross-sectional study. Both walking pace (slow, average, and brisk) and diabetes data were collected through self-reported methods. Fasting blood glucose (reported in mg/dl) and glycosylated haemoglobin A (HbA1c) scores were determined via blood exams. Results: In the unadjusted model, and compared to people who reported a slow walking pace, those with average and brisk walking pace had lower blood glucose levels (β = −7.74 mg/dL (95% CI: −11.08 to −4.40) and β = −11.05 mg/dL (95% CI: −14.36 to −7.75), respectively) and lower HbA1c (β = −0.34% (95% CI: −0.57 to −0.11) and β= −0.72% (95% CI: −0.94 to −0.49)), respectively. After adjusting for sociodemographic, Body Mass Index and lifestyle factors, the association between glycaemia and HbA1c remained only for brisk walkers. Both the average and brisk walker categories had lower odds of T2D (OR: 0.59 (95% CI: 0.41 to 0.84) and (OR 0.48 (95% CI: 0.30 to 0.79), respectively). Conclusion: Brisk walkers were associated with lower blood glucose and HbA1c levels. Moreover, average to brisk walking pace also showed a lower risk for T2D.